These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22183772)

  • 21. Prostate cancer cell survival pathways activated by bone metastasis microenvironment.
    Tenta R; Sotiriou E; Pitulis N; Thyphronitis G; Koutsilieris M
    J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):135-44. PubMed ID: 15951629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective.
    Ahmed M; Li LC
    Int J Urol; 2013 Apr; 20(4):362-71. PubMed ID: 23163774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen receptor is up-regulated by a BLT2-linked pathway to contribute to prostate cancer progression.
    Lee JW; Kim GY; Kim JH
    Biochem Biophys Res Commun; 2012 Apr; 420(2):428-33. PubMed ID: 22426480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation and prostate cancer.
    Vasto S; Carruba G; Candore G; Italiano E; Di Bona D; Caruso C
    Future Oncol; 2008 Oct; 4(5):637-45. PubMed ID: 18922121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
    Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
    Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer.
    Edwards J
    Expert Opin Investig Drugs; 2010 May; 19(5):605-14. PubMed ID: 20367532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance.
    Monet M; Lehen'kyi V; Gackiere F; Firlej V; Vandenberghe M; Roudbaraki M; Gkika D; Pourtier A; Bidaux G; Slomianny C; Delcourt P; Rassendren F; Bergerat JP; Ceraline J; Cabon F; Humez S; Prevarskaya N
    Cancer Res; 2010 Feb; 70(3):1225-35. PubMed ID: 20103638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer.
    Pootrakul L; Datar RH; Shi SR; Cai J; Hawes D; Groshen SG; Lee AS; Cote RJ
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5987-93. PubMed ID: 17062670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifaceted link between cancer and inflammation.
    Sethi G; Shanmugam MK; Ramachandran L; Kumar AP; Tergaonkar V
    Biosci Rep; 2012 Feb; 32(1):1-15. PubMed ID: 21981137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy.
    Bañez LL; Klink JC; Jayachandran J; Lark AL; Gerber L; Hamilton RJ; Masko EM; Vollmer RT; Freedland SJ
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):722-8. PubMed ID: 20160265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced but not localized prostate cancer is associated with increased oxidative stress.
    Yossepowitch O; Pinchuk I; Gur U; Neumann A; Lichtenberg D; Baniel J
    J Urol; 2007 Oct; 178(4 Pt 1):1238-43; discussion 1243-4. PubMed ID: 17698111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
    Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
    Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
    Kasper S
    J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgens and prostate cancer bone metastases: effects on both the seed and the soil.
    Yang W; Levine AC
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):643-53, x. PubMed ID: 21889726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of prostate cancer progression by the tumor microenvironment.
    Shiao SL; Chu GC; Chung LW
    Cancer Lett; 2016 Sep; 380(1):340-8. PubMed ID: 26828013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation and ovarian cancer.
    Macciò A; Madeddu C
    Cytokine; 2012 May; 58(2):133-47. PubMed ID: 22349527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.
    Kumar B; Koul S; Khandrika L; Meacham RB; Koul HK
    Cancer Res; 2008 Mar; 68(6):1777-85. PubMed ID: 18339858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-gamma-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)?
    Haddad JJ; Harb HL
    Mol Immunol; 2005 May; 42(9):987-1014. PubMed ID: 15829290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration.
    Liu Q; Tong D; Liu G; Gao J; Wang LA; Xu J; Yang X; Xie Q; Huang Y; Pang J; Wang L; He Y; Zhang D; Ma Q; Lan W; Jiang J
    Clin Cancer Res; 2018 Nov; 24(22):5622-5634. PubMed ID: 30012567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.